Zoledronate as a preventative measure for bone loss following denosumab discontinuation: results from a multi-institutional randomized controlled trial
AGING CLINICAL AND EXPERIMENTAL RESEARCH（2023）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined